Bolin Chen1,
Lin Wu1,
Min Yang2,
Jia Li1,
Li Xu1,
Kang Li1
For correspondence:- Kang Li Email: KayleySnyderlgb@yahoo.com
Accepted: 20 November 2019 Published: 31 December 2019
Citation: Chen B, Wu L, Yang M, Li J, Xu L, Li K. Comparative efficacy and safety of pemetrexed and crizotinib in Chinese patients with advanced lung cancer: A preliminary clinical trial. Trop J Pharm Res 2019; 18(12):2695-2699 doi: 10.4314/tjpr.v18i12.30
© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Archives
News Updates